Potential benefits of using GLP-1 receptor agonists after gastric sleeve surgery include: Enhanced weight loss : Observational studies suggest post-bariatric patients using GLP-1 receptor agonists may achieve additional weight reduction, typically around 510% of body weight, though individual responses vary considerably Improved glycaemic control : Particularly beneficial for patients with type 2 diabetes or prediabetes, as GLP-1 agonists enhance insulin secretion and reduce blood glucose levels Reduced appetite : These medications can help patients who struggle with persistent hunger despite surgical intervention Cardiovascular benefits : Semaglutide has demonstrated cardiovascular risk reduction in people with established cardiovascular disease, which may benefit eligible post-bariatric patients with this specific risk profile Maintenance of weight loss : May help prevent weight regain during the critical maintenance phase Potential risks and considerations include: Gastrointestinal side effects : Nausea, vomiting, diarrhoea, and constipation are common, particularly during dose escalation
"Doping control analysis of TB-500, a synthetic version of an active region of thymosin , in equine urine and plasma by liquid chromatography-mass spectrometry"
Why Proper Storage Matters Peptides are delicate compounds made up of amino acids
They are single-use sterile instruments
Oncology: Evaluates tumor growth and metastasis in preclinical cancer models
de Alwis R, Gan ES, Chen S, Leong YS, Tan HC, Zhang SL, et al
